Chronic obstructive pulmonary disease, with and without alpha-1-antitrypsin deficiency: Management practices in the U.K.

Respiratory Medicine

Volumn 93, Issue 7, 1999, Pages 481-490

  Hill, A T ^a   Campbell, E J ^b   Milford Ward, A ^c   Stockley, R A ^a  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^b UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

^c NORTHERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN;

ALPHA 1 ANTITRYPSIN DEFICIENCY; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC TEST; FOLLOW UP; HEALTH CARE POLICY; HOMOZYGOTE; HUMAN; LUNG FUNCTION TEST; LUNG VOLUME; NORMAL HUMAN; PHYSICIAN; PRIORITY JOURNAL; QUESTIONNAIRE; SCREENING TEST; THORAX RADIOGRAPHY; UNITED KINGDOM;

EID: 0032817710     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0954-6111(99)90091-4     Document Type: Article

References (27)

1. Sveger T. Alpha 1 antitrypsin deficiency in early childhood. Pediatrics 1978; 62: 22-25.
2. Stockley RA. Cellular and Biochemical Mechanisms in Chronic Obstructive Pulmonary Disease. London: Chapman and Hall, 1995: 93-133.
3. 1-globulin pattern of serum in alpha-1-antitrypsin deficiency. Scand J Clin Lab Invest 1963; 15: 132-140.
4. Eriksson S. Studies in alpha-1-antitrypsin deficiency. Acta Med Scand 1965; 432: 1-85.
5. Larsson C. Natural history and life expectancy in severe alpha-1-antitrypsin deficiency, Pi Z. Acta Med Scand 1978; 204: 345-351.
6. Sveger T, Eriksson S. The liver in adolescents with alpha-1-antitrypsin deficiency. Hepatology 1995; 22: 514-517.
7. Eriksson S, Carlson J, Velez R. Risk of cirrhosis and primary liver cancer in alpha 1-antitrypsin deficiency. N Engl J Med 1986; 314: 736-739.
8. Silverman EK, Miletich JP, Pierce JA et al. Alpha-1-antitrypsin deficiency. High prevalence in the St. Louis area determined by direct population screening. Am Rev Respir Dis 1989; 140: 961-966.
9. Thelin T, Sveger T, McNeil TF. Primary prevention in a high-risk group: smoking habits in adolescents with homozygous alpha-1-antitrypsin deficiency (ATD). Acta Paediatr 1996; 85: 1207-1212.
10. World Health Organisation. Alpha-1-antitrypsin Deficiency Memorandum from a World Health Organisation Meeting. Geneva: World Health Organisation 1996: 1-32.
11. Siafakas NM, Vermeire P, Pride NB, et al. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). Eur Respir J 1995; 8: 1398-1420.
12. British Thoracic Society. BTS guidelines for the management of chronic obstructive pulmonary disease. Thorax 1997; 52: S1-S28.
13. Brantly ML, Paul LD, Miller BH, Falk RT, Wu M, Crystal RG. Clinical features and history of the destructive lung disease associated with alpha-1-antitrypsin deficiency of adults with pulmonary symptoms. Am Rev Respir Dis 1988; 138: 327-336.
14. Piitulainen E, Tornling G, Eriksson S. Effect of age and occupational exposure to airway irritants on lung function in non-smoking individuals with alpha-1-antitrypsin deficiency (PiZZ). Thorax 1997; 52: 244-248.
15. Eden E, Mitchell D, Mehlman B et al. Atopy, asthma and emphysema in patients with severe a-1-antitrypsin deficiency. Am J Respir Crit Care Med 1997; 156: 68-74.
16. Muller NL, Miller RR, Abboud RT. 'Density Mask': an objective method to quantitate emphysema using computed tomography. Chest 1988; 94: 782-787.
17. Dirksen A, Friis M, Olesen KP, Skovgaard LT, Sorensen K. Progress of emphysema in severe aj-antitrypsin deficiency as assessed by annual CT. Acta Radiol 1997; 38: 826-832.
18. Gould GA, Redpath AT, Ryan M, Warren PM, Best JJK, Flenley DC, MacNee W. Lung CT density correlates with measurements of airflow limitation and the diffusing capacity. Eur Respir J 1991; 4: 141-146.
19. Dowson LJ, Guest PJ, Campbell EJ, Stockley RA. Progression of emphysema in patients with a-1 antitrypsin deficiency. Am J Respir Crit Care Med 1999; 159 (Suppl.): A822.
20. Crystal RG. Alpha 1-antitrypsin deficiency, emphysema, and liver disease. Genetic basis and strategies for therapy. J Clin Invest 1990; 85: 1343-1352.
21. Liou TG, Campbell EJ. Quantum proteolysis resulting from release of single granules by human neutrophils: a novel, non oxidative mechanism of extracellular proteolytic activity. J Immunol 1996; 157: 2624-2631.
22. Llewellyn-Jones CG, Harris TA, Stockley RA. Effect of fluticasone propionate on sputum of patients with chronic bronchitis and emphysema. Am J Respir Crit Care Med 1996; 153: 616-621.
23. 1 decline in individuals with severe deficiency of alpha-1-antitrypsin. Am J Respir Crit Care Med 1998; 158: 49-59.
24. Orell SR, Mazodier P. Pathological findings in alpha-1-antitrypsin deficiency. In: Mittman C, ed. Pulmonary Emphysema and Proteolysis. New York: Academic Press, 1972: 69-89.
25. King MA, Stone JA, Diaz PT, Mueller CF, Becker WJ, Gadek JE. Alpha 1-antitrypsin deficiency: evaluation of bronchiectasis with CT. Radiology 1996; 199: 137-141.
26. Fallat RJ. Reactive airway disease and alpha-1-antitrypsin deficiency. In: Crystal RG, ed. Alpha-1-antitrypsin Deficiency; Biology, Pathogenesis, Clinical Manifestations, Therapy. New York: Marcel Dekker, 1996: 259-279.
27. Seersholm N, Kok-Jensen A, Dirksen A. Survival of patients with severe alpha-1-antitrypsin deficiency with special reference to non index cases. Thorax, 994; 94: 695-698.